---
title: HR 7. Endometrial cancer as public health concern; recognize
collection: bills
id: 2026-special/hr7
cite_as: HR 7, 2026 Special Session (Ga.)
canonical_url: https://georgiacommons.org/bills/2026-special/hr7
md_url: https://georgiacommons.org/bills/2026-special/hr7.md
text_url: https://georgiacommons.org/bills/2026-special/hr7/text
source_url: https://www.legis.ga.gov/legislation/74798
date: 2026-06-17
status: passed
corpus_version: bills-2026-09-13
license: Public record of the Georgia General Assembly, via LegiScan; see about.md
publisher: Georgia Commons, an independent project of Georgia Civic Data. Not the State of Georgia. Not legal advice.
up: https://georgiacommons.org/bills/2026-special.md
previous: https://georgiacommons.org/bills/2026-special/hr6.md
next: https://georgiacommons.org/bills/2026-special/hr8.md
index: https://georgiacommons.org/bills/index.md
omitted: votes and history
omitted_chars: 131
omitted_url: https://georgiacommons.org/bills/2026-special/hr7.md?full=1
bill_number: HR 7
session: 2026 Special Session
session_slug: 2026-special
chamber: House
bill_type: resolution
status_date: 2026-06-17
last_action: House Read and Adopted
sponsors:
  - Kim Schofield
  - Viola Davis
  - Sandra Scott
  - Marvin Lim
  - Park Cannon
text_version: Introduced
has_text: true
legiscan_url: https://legiscan.com/GA/bill/HR7/2026/X1
upstream_id: 2154018
summaries_model: claude-sonnet-5
topic_tags:
  - endometrial cancer
  - women's health
  - public health awareness
  - cancer disparities
---

# HR 7. Endometrial cancer as public health concern; recognize

## Text

House Resolution 7EX
By: Representatives Schofield of the 63rd, Davis of the 87th, Scott of the 76th, Lim of the 98th,
and Cannon of the 58th
A RESOLUTION
Recognizing endometrial cancer as a significant public health concern in the State of Georgia
and promoting broad awareness and the importance of prevention, screening, and treatment;
and for other purposes.
WHEREAS, endometrial cancer, the most common type of uterine cancer, accounts for
approximately 95 percent of all uterine cancer cases and develops when cells in the lining
of the uterus mutate or change and become malignant; and
WHEREAS, it ranks as the most common gynecologic malignancy in the United States, with
approximately 66,000 cases diagnosed annually; and
WHEREAS, endometrial cancer primarily affects postmenopausal women, with the average
age at diagnosis being approximately 60 years, and is uncommon among women younger
than 45 years of age; and
WHEREAS, uterine cancer incidence has increased in recent decades and is now the fourth
most common cancer in women; and
H. R. 7EX
WHEREAS, approximately 3.1 percent of women in the United States will be diagnosed
with uterine cancer during their lifetime, and nearly 900,000 women are currently living with
a history of uterine cancer; and
WHEREAS, data from the Georgia Comprehensive Cancer Registry within the Georgia
Department of Public Health indicates that from 2019 through 2023, the incidence rate of
uterine corpus cancer (cancer of the body of the uterus) among women in Georgia was 25.4
cases per 100,000 women, and from 2020 through 2024, the mortality rate from uterine
corpus cancer was 5.6 deaths per 100,000 women; and
WHEREAS, the uterine corpus cancer death rate in Black women is almost double that in
White women (9.0 versus 4.6 deaths per 100,000, respectively), likely due to disparities in
access to high-quality care; and
WHEREAS, in 2026, an estimated 68,270 cases of uterine corpus cancer will be diagnosed
and an estimated 14,450 women will die from the disease in the United States, of which an
estimated 2,050 diagnosed cases and 490 deaths are projected to occur in the State of Georgia
alone; and
WHEREAS, factors that increase an individual's risk of developing endometrial cancer
include older age, obesity, hormonal changes, early menstruation, late menopause, genetic
predisposition, and taking hormone therapy for breast cancer; and
WHEREAS, common symptoms of endometrial cancer, including abnormal uterine bleeding,
postmenopausal bleeding, pelvic pain, and other gynecologic symptoms, may serve as
important warning signs that warrant prompt medical evaluation; and
H. R. 7EX
WHEREAS, while there are no standard routine screening tests for endometrial cancer, there
are several methods currently under study in clinical trials including pap test, transvaginal
ultrasound, and endometrial sampling; and
WHEREAS, because endometrial cancer frequently presents with early symptoms, including
abnormal vaginal bleeding, approximately 68 percent of cases are diagnosed at an early
stage, when treatment outcomes are generally most favorable; and
WHEREAS, the five-year survival rate for endometrial cancer is 96 percent when diagnosed
at an early stage and remains confined to the uterus, but it falls to 22 percent once the cancer
has spread to distant organs, underscoring the critical importance of early detection and
timely treatment; and
WHEREAS, treatment for endometrial cancer varies based on the stage and characteristics
of the disease and may include surgery, radiation therapy, chemotherapy, hormone therapy,
targeted therapy, immunotherapy, or a combination of these approaches; and
WHEREAS, increasing awareness among patients, caregivers, healthcare professionals, and
policymakers can contribute to earlier diagnosis, improved access to care, and better health
outcomes; and
WHEREAS, recognizing endometrial cancer and raising awareness of its impact can help
foster greater understanding of the disease and encourage individuals to seek appropriate
medical care when symptoms arise; and
WHEREAS, increased investment in endometrial cancer research is urgently needed to
develop better screening methods, improve treatment options, and reduce mortality,
H. R. 7EX
particularly for Black and other high-risk populations disproportionately represented in
Georgia.
NOW, THEREFORE, BE IT RESOLVED BY THE HOUSE OF REPRESENTATIVES that
the members of this body recognize endometrial cancer as a serious and growing public
health treat affecting women across Georgia and the nation and the importance of increasing
awareness of endometrial cancer and its impact on individuals, families, caregivers, and
communities.
BE IT FURTHER RESOLVED that the Clerk of the House of Representatives is authorized
and directed to make appropriate copies of this resolution available for distribution to the
public and the press.
H. R. 7EX

## Summaries written by Georgia Commons

The following was written by claude-sonnet-5 from the text above and is not part of the resolution. Quote the text, not the summary.

A Georgia House resolution formally recognizes endometrial cancer as a serious and growing public health concern affecting women across the state, aiming to raise awareness of prevention, screening, and treatment.

### Plain-language summary

This resolution does not change Georgia law or create new programs. Instead, it is a formal statement from the Georgia House of Representatives recognizing endometrial cancer, the most common type of uterine cancer, as a significant public health issue in Georgia.

The resolution cites data from the Georgia Comprehensive Cancer Registry showing uterine corpus cancer incidence and mortality rates in Georgia, including a racial disparity in death rates between Black and White women. It notes that thousands of Georgians are projected to be diagnosed with or die from the disease in 2026. The resolution concludes by directing the Clerk of the House to distribute copies to the public and press, encouraging awareness of symptoms, screening research, and treatment options.

### What it does

- Formally recognizes endometrial cancer as a serious and growing public health concern for women in Georgia and the nation.
- Cites Georgia-specific data on uterine corpus cancer incidence, mortality, and racial disparities from the Georgia Comprehensive Cancer Registry.
- Directs the Clerk of the House of Representatives to distribute copies of the resolution to the public and press.
- Does not create funding, new screening requirements, or changes to Georgia statutes; it is a statement of legislative recognition only.

### Who it affects

Women in Georgia, particularly postmenopausal women and Black women who face higher mortality rates from uterine corpus cancer, along with healthcare professionals, caregivers, and public health researchers focused on cancer awareness and treatment.

### Why it matters

While the resolution carries no legal force, it puts the Georgia House on record highlighting a health disparity, with Black women facing nearly double the death rate of White women from uterine corpus cancer, and may encourage public attention to symptoms, research, and access to care.

### Key provisions

- The whereas clauses describe endometrial cancer's prevalence, risk factors, symptoms, and survival rates, including a 96 percent five-year survival rate when caught early versus 22 percent when spread to distant organs.
- The resolution cites Georgia Department of Public Health data showing a uterine corpus cancer incidence rate of 25.4 cases per 100,000 women and a mortality rate of 5.6 deaths per 100,000 women in Georgia.
- The resolved clause has the House formally recognize endometrial cancer as a public health concern and the importance of awareness.
- The final clause directs the Clerk of the House to make copies available to the public and press.

## Status

- Status: Passed (2026-06-17)
- Last action: House Read and Adopted (2026-06-17)
- Sponsors: Kim Schofield, Viola Davis, Sandra Scott, Marvin Lim, Park Cannon
- Official page: https://www.legis.ga.gov/legislation/74798

> The history, votes, and amendments (131 characters) are at https://georgiacommons.org/bills/2026-special/hr7.md?full=1